By Nick Kostov 

PARIS--Sanofi SA on Thursday said it has made an all-cash offer to acquire Medivation Inc. in a deal valued at $9.3 billion, the French drugmaker's latest effort to expand its cancer-treatment business.

Sanofi said it would pay $52.50 a Medivation share, a premium of over 50% to Medivation's average share price for the two months before speculation of a takeover surfaced.

Write to Nick Kostov at Nick.Kostov@wsj.com

 

(END) Dow Jones Newswires

April 28, 2016 02:45 ET (06:45 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Sanofi Charts.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Sanofi Charts.